摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-ethyl-1,5,7-triazabicyclo<4.4.0>dec-5-ene | 95510-44-4

中文名称
——
中文别名
——
英文名称
7-ethyl-1,5,7-triazabicyclo<4.4.0>dec-5-ene
英文别名
7-Ethyl-1,5,7-triazabicyclo(4.4.0)dec-5-ene;1-ethyl-2,3,4,6,7,8-hexahydropyrimido[1,2-a]pyrimidine
7-ethyl-1,5,7-triazabicyclo<4.4.0>dec-5-ene化学式
CAS
95510-44-4
化学式
C9H17N3
mdl
——
分子量
167.254
InChiKey
AAPJUEKLMYSSCH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    312.2±11.0 °C(Predicted)
  • 密度:
    1.14±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.3
  • 重原子数:
    12
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.89
  • 拓扑面积:
    18.8
  • 氢给体数:
    0
  • 氢受体数:
    1

SDS

SDS:b29db2d9ebfde0c8e3af9ce1b40ecd32
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    参考文献:
    名称:
    [EN] METHODS TO PRODUCE ALKYLATED POLYCYCLIC GUANIDINE COMPOUNDS
    [FR] PROCÉDÉS DE FABRICATION DE COMPOSÉS GUANIDINES POLYCYCLIQUES ALKYLÉES
    摘要:
    本发明涵盖了通过与二烷基碳酸酯反应合成具有可交换NH基团的多环胍基N-烷基衍生物的方法。在一个方面,本发明提供了一种通过加热TBD和二甲基碳酸酯的混合物制备甲基TBD(1-甲基-1,4,9-三氮杂双环[4.4.0]庚-9-烯)的方法。
    公开号:
    WO2013055747A1
点击查看最新优质反应信息

文献信息

  • [EN] PROCESS FOR THE SYNTHESIS OF FLUORALKYL SULFONATE SALTS<br/>[FR] PROCÉDÉ DE SYNTHÈSE DE SELS DE SULFONATE DE FLUORALKYLE
    申请人:SOLVAY SPECIALTY POLYMERS IT
    公开号:WO2015049239A1
    公开(公告)日:2015-04-09
    A process for the preparation of the fluoroalkyl sulfonate salt of a nitrogen-based organic base said process comprising the step of reacting a fluoroalkyl sulfonyl halide with an organic base selected from the group consisting of tertiary amines, pyridines, amidines and guanidines.
    一种制备氟烷基磺酸盐的氮基有机碱的过程,该过程包括将氟烷基磺酰卤与从三级胺、吡啶、脲和胍组成的有机碱反应的步骤。
  • Continuous method for preparing carbonate esters
    申请人:UCHICAGO ARGONNE, LLC
    公开号:US11028065B1
    公开(公告)日:2021-06-08
    In one embodiment, a continuous process for preparing organic carbonate solvent of Formula (I) as described herein comprises contacting a first reactant (an alcohol) with a reactive carbonyl source (carbonyldiimidazole (CDI) or an alkylchloroformate) in the presence of a catalyst in reaction stream flowing through a continuous flow reactor at temperature 20° C. to about 160° C. and at a flow rate providing a residence time in the range of about 0.1 minute to about 24 hours; collecting a reactor effluent exiting from the continuous flow reactor; recovering a crude product from the reactor effluent; and distilling the crude product to obtain the organic carbonate compound of Formula (I). In another embodiment, the first reactant is an epoxide and the carbonyl source is carbon dioxide.
    在一种实施例中,制备有机碳酸酯溶剂的连续过程包括将第一反应物(醇)与具有反应性的羰基源(羰基二咪唑(CDI)或烷基氯甲酸酯)在催化剂存在下接触,通过连续流动反应器中的反应流在温度为20°C至约160°C的条件下,并以提供在约0.1分钟到约24小时范围内的停留时间的流速;收集从连续流动反应器中流出的反应器流出物;从反应器流出物中回收粗产品;并蒸馏粗产品以获得化合物的有机碳酸酯的配方(I)。在另一种实施例中,第一反应物是环氧化物,而羰基源是二氧化碳。
  • Method for preparing bis-(silylalkyl)carbonate esters
    申请人:UCHICAGO ARGONNE, LLC
    公开号:US10556917B1
    公开(公告)日:2020-02-11
    Carbonate esters of Formula (I): (R1)(R2)(R3)Si—R4—O—C(═O)—O—R4—Si(R1)(R2)(R3) are prepared by reaction of a silyl-substituted alcohol of Formula (II): (R1)(R2)(R3)Si—R4—OH with an activated carbonyl compound of Formula (III): C(═O)Z2 in the presence of a catalyst (e.g., an bicyclic amidine, a bicyclic guanidine, or a phosphazene) in an aprotic solvent. In Formulas (I) and (II) each of R1 and R2 independently is alkyl; R3 is alkyl or —X1—Si(R5)(R6)(R7); X1 is O or alkylene; R4 is alkylene; and each R5, R6, and R7 independently is alkyl. In Formula (III), Z is 1-N-imidazolyl or 1-N-succinimidyl. In some embodiments, the catalyst used in the methods described herein comprises at least one base selected from the group consisting of a bicyclic amidine and a bicyclic guanidine. The reaction proceeds readily under both bulk and continuous flow reactor conditions.
    公式(I)的碳酸酯:(R1)(R2)(R3)Si—R4—O—C(═O)—O—R4—Si(R1)(R2)(R3)是通过在无水溶剂中存在催化剂(例如双环胺、双环胍或磷氮烷)的情况下,将公式(II)的硅烷基取代醇:(R1)(R2)(R3)Si—R4—OH与公式(III)的活化羰基化合物:C(═O)Z2反应制备的。在公式(I)和(II)中,每个R1和R2独立地是烷基;R3是烷基或—X1—Si(R5)(R6)(R7);X1是O或烷基;R4是烷基;每个R5、R6和R7独立地是烷基。在公式(III)中,Z是1-N-咪唑基或1-N-琥珀酰亚胺基。在某些实施方式中,所述方法中使用的催化剂包括从双环胺和双环胍组中选择的至少一种碱。反应在大块和连续流反应器条件下均能顺利进行。
  • CURABLE-ON-DEMAND COMPOSITION COMPRISING DUAL REACTIVE SILANE FUNCTIONALITY
    申请人:Yang Yu
    公开号:US20130178553A1
    公开(公告)日:2013-07-11
    A curable composition comprises (a) at least one inorganic or organic compound comprising reactive silane functionality comprising at least one hydrosilyl moiety; (b) at least one inorganic or organic compound comprising reactive silane functionality comprising at least one hydroxysilyl moiety, the hydroxysilyl moiety optionally being generated in situ by hydrolysis of at least one hydrosilyl moiety; and (c) at least one photoactivatable composition that, upon exposure to radiation, generates at least one base selected from amidines, guanidines, phosphazenes, proazaphosphatranes, and combinations thereof; with the proviso that, when component (a) is an organic polymer, then component (b) is different from component (a) and is not generated in situ by hydrolysis of component (a).
    一种可治愈的组合物包括:(a)至少一种含有反应性硅烷官能团的无机或有机化合物,其中硅烷官能团包括至少一个氢硅烷基;(b)至少一种含有反应性硅烷官能团的无机或有机化合物,其中硅烷官能团包括至少一个羟基硅烷基,羟基硅烷基可以通过至少一个氢硅烷基的水解而在原位生成;以及(c)至少一种光活性组合物,当暴露于辐射下时,生成至少一种从氨基甲酸酰胺、鸟嘌呤、磷氮烷、丙氨酸磷酸酯和其组合物中选择的碱,前提是当组分(a)是有机聚合物时,组分(b)与组分(a)不同,并且不是通过组分(a)的水解在原位生成的。
  • CURABLE-ON-DEMAND POLYSILOXANE COATING COMPOSITION
    申请人:Yang Yu
    公开号:US20130101841A1
    公开(公告)日:2013-04-25
    A curable composition comprises (a) at least one polydiorganosiloxane, fluorinated polydiorganosiloxane, or combination thereof comprising reactive silane functionality comprising at least two hydroxysilyl moieties; (b) at least one polydiorganosiloxane, fluorinated polydiorganosiloxane, or combination thereof comprising reactive silane functionality comprising at least two hydrosilyl moieties; and (c) at least one photoactivatable composition that, upon exposure to radiation, generates at least one base selected from amidines, guanidines, phosphazenes, proazaphosphatranes, and combinations thereof; wherein at least one of the components (a) and (b) has an average reactive silane functionality of at least three.
    可治疗组合物包括:(a)至少一种聚二甲基硅氧烷、氟代聚二甲基硅氧烷或二者的组合物,其包含具有至少两个羟基硅基的反应性硅烷官能团;(b)至少一种聚二甲基硅氧烷、氟代聚二甲基硅氧烷或二者的组合物,其包含具有至少两个氢硅基的反应性硅烷官能团;以及(c)至少一种光致活性组分,当暴露于辐射下时,会产生从氨基化合物、胍化合物、磷氮化合物、脲基磷杂环丙烷和它们的组合物中选择的至少一种碱;其中,组分(a)和/或(b)中至少有一种的平均反应性硅烷官能团为至少三个。
查看更多